Estimated Annual Spending on Aducanumab in the US Medicare Program

被引：14

作者：

Mafi, John N. ^{[1
,2
,3
]}

Leng, Mei ^{[2
]}

Arbanas, Julia Cave ^{[2
]}

Tseng, Chi-Hong ^{[2
]}

Damberg, Cheryl L. ^{[3
]}

Sarkisian, Catherine ^{[2
,4
]}

Landon, Bruce E. ^{[5
,6
]}

机构：

[1] UCLA, David Geffen Sch Med, Dept Med, Div Gen Med & Hlth Serv Res, 1100 Glendon Ave 908, Los Angeles, CA 90024 USA

[2] UCLA, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA

[3] RAND Corp, Santa Monica, CA USA

[4] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA

[5] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02115 USA

[6] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA

来源：

JAMA HEALTH FORUM | 2022年 / 3卷 / 01期

关键词：

D O I：

10.1001/jamahealthforum.2021.4495

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

This cross-sectional study examines upper bound and lower bound annualized Medicare costs for administering aducanumab to beneficiaries with the approved indications of mild cognitive impairment or mild dementia.

引用

页数：5

共 6 条

[1] Assessment of Cognition Using Surveys and Neuropsychological Assessment: The Health and Retirement Study and the Aging, Demographics, and Memory Study
Crimmins, Eileen M.
Kim, Jung Ki
Langa, Kenneth M.
Weir, David R.
[J]. JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES, 2011, 66 : 162 - 171
[2] Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study
Doraiswamy, P. M.
Sperling, R. A.
Johnson, K.
Reiman, E. M.
Wong, T. Z.
Sabbagh, M. N.
Sadowsky, C. H.
Fleisher, A. S.
Carpenter, A.
Joshi, A. D.
Lu, M.
Grundman, M.
Mintun, M. A.
Skovronsky, D. M.
Pontecorvo, M. J.
[J]. MOLECULAR PSYCHIATRY, 2014, 19 (09) : 1044 - 1051
[3] Kaiser Family Foundation, FDAS APPR BIOG NEW A
[4] National estimates of the quantity and cost of informal caregiving for the elderly with dementia
Langa, KM
Chernew, ME
Kabeto, MU
Herzog, AR
Ofstedal, MB
Willis, RJ
Wallace, RB
Mucha, LM
Straus, WL
Fendrick, AM
[J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2001, 16 (11) : 770 - 778
[5] Lin GA., ADUCANUMAB ALZHEIMER
[6] U.S. Food and Drug Administration, CTR DRUG EV RES CLIN

← 1 →